1. International Agency for Research on Cancer, “IARC monographs on the identification of carcinogenic hazards to humans”, https://monographs.iarc.who.int/list-of-classifications
2. Peto R, Gray R, Brantom P, Grasso P. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res. 1991;51:6452–69.
3. Food and Drug Administration, (FDA), “FDA updates and press announcements on angiotensin II receptor blocker (ARB) recalls (Valsartan, Losartan, and Irbesartan)”, https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan
4. Food and Drug Administration, (FDA), “FDA updates and press announcements on NDMA in metformin”, https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-metformin
5. Food and Drug Administration, (FDA), “FDA updates and press announcements on NDMA in ranitidine (Zantac)”, https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine